https://www.selleckchem.com/pr....oducts/Telaprevir(VX
A risk score of 0-4 (low risk) predicted a mortality of 3.7%,a risk score of 5-15 (Intermediate risk) predicted a mortality of 16.4% and a risk score of 11-15 predicted a mortality of 32.0% over a 6-month period. The new risk score was noninferior to GRACE risk score in its predictive accuracy of 6-month mortality in the same cohort of patients (p0.05). The risk score developed in our study can be easily calculated at the bedside and is aimed at identifying high risk patients who require more intense follow up after disch
Curtir
Comentario
Compartilhar
